Medivir Aktiebolag financials
Medivir Aktiebolag
549300VWDGUX0WMJ1T79 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | SEK 27.2M | SEK 27.4M |
| Depreciation & amortisation | SEK 2.7M | SEK 2.7M |
| Operating profit (EBIT) | -SEK 127.3M | -SEK 91.4M |
| Finance costs | SEK 783.0K | SEK 913.0K |
| Profit before tax | -SEK 123.3M | -SEK 89.3M |
| Profit for the year | -SEK 123.3M | -SEK 89.3M |
| — attributable to owners | -SEK 123.3M | -SEK 89.3M |
| Total comprehensive income | -SEK 123.3M | -SEK 89.4M |
| Per share | ||
| Basic EPS | SEK -1.08 | SEK -1.48 |
| Diluted EPS | SEK -1.08 | SEK -1.48 |
| Free cash flow / share | SEK -1.09 | SEK -0.99 |
| Cash flow statement | ||
| Cash generated from operations | -SEK 119.3M | -SEK 86.1M |
| Net cash from operating activities | -SEK 124.2M | -SEK 59.7M |
| Net cash from investing activities | SEK 0 | -SEK 261.0K |
| Purchase of PP&E (capex) | SEK 0 | SEK 0 |
| Net cash from financing activities | SEK 17.2M | SEK 112.1M |
| Lease liability payments | SEK 2.5M | SEK 2.0M |
| Net change in cash | -SEK 107.0M | SEK 52.1M |
| Balance sheet | ||
| Total assets | SEK 172.6M | SEK 287.9M |
| Non-current assets | SEK 105.9M | SEK 108.7M |
| Property, plant & equipment | SEK 9.6M | SEK 12.4M |
| Right-of-use assets | SEK 9.6M | SEK 12.2M |
| Current assets | SEK 66.6M | SEK 179.2M |
| Trade & other receivables | SEK 4.1M | SEK 9.7M |
| Cash & equivalents | SEK 62.5M | SEK 169.5M |
| Total equity | SEK 115.5M | SEK 217.9M |
| Non-current liabilities | SEK 8.6M | SEK 11.3M |
| Lease liabilities (non-current) | SEK 8.6M | SEK 11.3M |
| Current liabilities | SEK 48.5M | SEK 58.7M |
| Lease liabilities (current) | SEK 2.5M | SEK 2.3M |
| Derived metrics | ||
| Free cash flow | -SEK 124.2M | -SEK 59.7M |
| Return on equity | -106.8% | -41.0% |
| Cash conversion ratio | 1.01× | 0.67× |
| Other reported items | ||
| Additional Paidin Capital | SEK 926.0M | SEK 910.3M |
| Adjusted Weighted Average Shares | 114.1M | 60.4M |
| Adjustments For Decrease Increase In Trade and Other Receivables | SEK 5.6M | -SEK 4.1M |
| Adjustments For Increase Decrease In Trade and Other Payables | -SEK 10.4M | SEK 30.6M |
| Cash | SEK 10.8M | SEK 25.6M |
| Cash Equivalents | SEK 51.7M | SEK 144.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -SEK 119.3M | -SEK 86.1M |
| Current Accrued Expenses and Other Current Liabilities | SEK 32.5M | SEK 38.8M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | SEK 1.8M | SEK 6.9M |
| Current Tax Assets Current | SEK 1.4M | SEK 1.4M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 0 | -SEK 64.0K |
| Equity and Liabilities | SEK 172.6M | SEK 287.9M |
| Finance Income | SEK 4.8M | SEK 3.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | SEK 0 | -SEK 64.0K |
| Increase Decrease Through Exercise of Warrants Equity | SEK 1.6M | SEK 1.2M |
| Intangible Assets Other Than Goodwill | SEK 96.3M | SEK 96.3M |
| Intangible Assets Under Development | SEK 96.3M | SEK 96.3M |
| Issue of Equity | SEK 20.0M | SEK 129.0M |
| Issued Capital | SEK 57.3M | SEK 52.7M |
| Miscellaneous Other Operating Expense | SEK 639.0K | SEK 1.4M |
| Noncurrent Financial Assets | SEK 0 | SEK 0 |
| Number of Shares Outstanding | 114.6M | 105.4M |
| Other Adjustments For Noncash Items | SEK 4.0M | SEK 3.2M |
| Other Comprehensive Income | SEK 0 | -SEK 64.0K |
| Other Current Payables | SEK 1.4M | SEK 1.3M |
| Other Current Receivables | SEK 889.0K | SEK 1.3M |
| Other Expense By Nature | SEK 101.3M | SEK 68.9M |
| Other Intangible Assets | SEK 0 | SEK 0 |
| Other Noncurrent Financial Assets | SEK 0 | SEK 0 |
| Other Operating Income Expense | SEK 978.0K | SEK 1.4M |
| Other Property Plant and Equipment | SEK 85.0K | SEK 212.0K |
| Par Value Per Share | SEK 0.50 | SEK 0.50 |
| Payments For Share Issue Costs | SEK 700.0K | SEK 15.7M |
| Proceeds From Issuing Other Equity Instruments | SEK 0 | SEK 0 |
| Proceeds From Issuing Shares | SEK 20.4M | SEK 129.7M |
| Purchase of Other Longterm Assets Classified As Investing Activities | SEK 0 | SEK 261.0K |
| Reserve of Exchange Differences On Translation | -SEK 3.3M | -SEK 3.3M |
| Retained Earnings | -SEK 864.5M | -SEK 741.7M |
| Revenue and Operating Income | SEK 4.5M | SEK 9.0M |
| Revenue From Royalties | SEK 3.5M | SEK 7.6M |
| Share Issue Related Cost | SEK 700.0K | SEK 15.7M |
| Trade and Other Current Payables To Trade Suppliers | SEK 12.1M | SEK 16.4M |
| Weighted Average Shares | 114.1M | 60.4M |
Every line item above is a fact tagged in Medivir Aktiebolag's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.